Antibody-Drug Conjugates (ADCs)
Also called ADCs. They act in these three steps:
1. Bind selectively to the malignant cell's antibody.
2. Doing this allows to enter directly into the tumorous cell.
3. Release cytotoxic molecules that kill the malignant cell.

Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.